79 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
injury or death, to the extent such Third Party Claims arise from the period of time commencing on or after the Effective Date and to the extent … Product on or after the Effective Date, including, without limitation, any Third Party Claim for personal injury or death, to the extent such Third Party
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
basis to fair market value for the common shares at the date of the death and instead will have a tax basis equal to the decedent’s tax basis if lower
8-K/A
EX-10.1
FENC
Fennec Pharmaceuticals Inc
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
to participate in any group life insurance plan, group medical and/or dental insurance plan, accidental death and dismemberment plan, short-term … of the Company's proprietary information.
E. Employee’s employment shall automatically terminate in the event of Employee’s death or permanent disability
8-K
EX-10.1
d4x98i6 zwvq
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
424B3
uifa5bnfk3
15 Dec 22
Prospectus supplement
5:12pm
424B5
wkyc p5i95kapjrkz2f
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
tzzi6s
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-10.1
tjbk3jwnh1ssgvxnc
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm